Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Rankning i aktier #27739
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Aktiekurs
$2.14
Marknadsvärde
$30.63M
Förändring (1 dag)
0.16%
Förändring (1 år)
-62.09%
Land
KR
Handel IMBdx (461030)

Kategori

Aktiekurshistorik för IMBdx (461030)
Högsta slutkurs: $2.31 den 2026-08-01

Lägsta slutkurs: $14.99 den 2024-04-01
Aktiekurshistorik för IMBdx från 2024 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -26.19%
2025 -3.47%
2024 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$753.28 5.84%
CH